This test detects 348 genes, including HRR pathway genes. The content involves targeted breast cancer therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for breast cancer patients. Features of Individualized Breast Cancer Medication Applicable Population of Individualized Medication Guidance for Breast Cancer Late-stage newly diagnosed breast cancer patients who need targeted therapy and immunotherapy. Patients with relapsed, drug-resistant breast cancer. Breast cancer patients who need targeted therapy and immunotherapy through liquid biopsy.
and breast cancer genetic test, please visit our website.
Corporation and Biochip Beijing National Engineering Research Center and one of the core enterprises of Tsinghua University in the field of life and health. CapitalBio Technology was registered and established in August 2012 and had production, R&D bases and marketing operation centers for biochips, instrument and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong (China) and San Diego and other places, with a total office area of over 150,000 ㎡ and employees of over 2,000 persons.
life sciences instruments
